Oxford Immunotec Global PLC (OXFD.OQ) Key Developments | Reuters.com
Edition:
United States

Analyst Research

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Stock Traders Daily
$20.00
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Oxford Immunotec Global PLC gives Q3 2014 revenue guidance below analysts' estimates; raises low end of prior FY 2014 revenue guidance


Tuesday, 5 Aug 2014 07:00am EDT 

Oxford Immunotec Global PLC:Expect to report revenue of between $12.4 and $12.9 million for Q3 2014, and between $48 and $50 million for FY 2014.Q3 2014 revenue of $13.4 million - Thomson Reuters I/B/E/S.FY 2014 revenue of $50 million - Thomson Reuters I/B/E/S.